Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-21
DOI
10.1038/s41598-021-00268-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of Potential Genomic Alterations and the circRNA-miRNA-mRNA Regulatory Network in Primary and Recurrent Synovial Sarcomas
- (2021) Qing Yao et al. Frontiers in Molecular Biosciences
- Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
- (2020) Tian-Fu Li et al. Cancer Cell International
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- (2020) Sandra M Swain et al. LANCET ONCOLOGY
- Ubiquitin chain-elongating enzyme UBE2S activates the RING E3 ligase APC/C for substrate priming
- (2020) Raquel C. Martinez-Chacin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer
- (2020) Tao Xu et al. Oncology Letters
- NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
- (2020) Cuicui Xiao et al. Frontiers in Pharmacology
- NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer
- (2020) Lili Jiang et al. Cell Death & Disease
- The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer
- (2020) Minakshi Gandhi et al. Nature Communications
- Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells
- (2020) Fei Peng et al. CELL RESEARCH
- Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets
- (2020) Lisa Dwane et al. NUCLEIC ACIDS RESEARCH
- Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
- (2019) Jiyoung Lee et al. NATURE
- Immunotherapy and targeted therapy combinations in metastatic breast cancer
- (2019) Francisco J Esteva et al. LANCET ONCOLOGY
- A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
- (2019) Juan Bayo et al. JOURNAL OF HEPATOLOGY
- A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
- (2019) Ying Z. Mazzu et al. CLINICAL CANCER RESEARCH
- Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy
- (2019) Iris Uribesalgo et al. EMBO Molecular Medicine
- Prognostic value of DLGAP5 in colorectal cancer
- (2019) Vittorio Branchi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Novel key genes in triple‐negative breast cancer identified by weighted gene co‐expression network analysis
- (2019) Jian Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases
- (2019) Franziska Maria Ippen et al. NEURO-ONCOLOGY
- Acetylation regulates ribonucleotide reductase activity and cancer cell growth
- (2019) Guo Chen et al. Nature Communications
- Identification of new octamer transcription factor 1‐target genes upregulated in castration‐resistant prostate cancer
- (2019) Shinichiro Yamamoto et al. CANCER SCIENCE
- Identification of a functional polymorphism within the 3′-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma
- (2019) Lu Yang et al. EUROPEAN JOURNAL OF CANCER
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Efficacy of PI3K inhibitors in advanced breast cancer
- (2019) B Verret et al. ANNALS OF ONCOLOGY
- Feature article: Silencing PSME3 induces colorectal cancer radiosensitivity by downregulating the expression of cyclin B1 and CKD1
- (2019) Wen Song et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Identification of lncRNA NEAT1/miR‐21/RRM2 axis as a novel biomarker in breast cancer
- (2019) Dongling Quan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
- (2019) Bin Li et al. Journal of Translational Medicine
- Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
- (2019) Neil Vasan et al. SCIENCE
- The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis
- (2019) Luisa Capalbo et al. Nature Communications
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
- (2018) Hayley J. Donnella et al. Nature Chemical Biology
- Prognostic and predictive value of HURP in non‑small cell lung cancer
- (2018) Qi Wang et al. ONCOLOGY REPORTS
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer
- (2018) Juan Zhou et al. Cancer Research and Treatment
- Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression
- (2018) Xi Zhang et al. MEDICAL SCIENCE MONITOR
- SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
- (2017) Vural Tagal et al. Nature Communications
- Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer
- (2017) Yuan-Xiang Shi et al. Scientific Reports
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer
- (2017) Miho Kono et al. JAMA Oncology
- Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases
- (2017) Lupe G. Salazar et al. JAMA Oncology
- The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
- (2016) Jianxiang Chen et al. GUT
- Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients
- (2016) Tatsuya Kato et al. LUNG CANCER
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
- (2016) Feimeng Zheng et al. Nature Communications
- Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
- (2015) Bohuslav Melichar et al. LANCET ONCOLOGY
- Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma
- (2015) Hiroki Kobayashi et al. Oncotarget
- Cyclin B2 and p53 control proper timing of centrosome separation
- (2014) Hyun-Ja Nam et al. NATURE CELL BIOLOGY
- Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions
- (2014) Chen-Pin Chou et al. PLoS One
- Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
- (2013) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining NOTCH3 Target Genes in Ovarian Cancer
- (2012) X. Chen et al. CANCER RESEARCH
- Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer
- (2012) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
- (2011) A. Psyrri et al. ANNALS OF ONCOLOGY
- Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients
- (2011) Maria Candida B V Fragoso et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started